Related references
Note: Only part of the references are listed.Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation
C-H Yan et al.
BONE MARROW TRANSPLANTATION (2016)
Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation
Karen Ballen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation
Evelyn Rustia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood
Michelle A. E. Jansen et al.
JOURNAL OF PEDIATRICS (2016)
Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients
A. Ruggeri et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis
R. Crocchiolo et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Timeline, Epidemiology, and Risk Factors for Bacterial, Fungal, and Viral Infections in Children and Adolescents after Allogeneic Hematopoietic Stem Cell Transplantation
Ashok Srinivasan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
Jennifer A. Kanakry et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients
P. Hiwarkar et al.
BONE MARROW TRANSPLANTATION (2013)
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT
J. Rahiala et al.
BONE MARROW TRANSPLANTATION (2013)
Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience
A. Verdeguer et al.
BONE MARROW TRANSPLANTATION (2011)
Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update
Ruth Seggewiss et al.
BLOOD (2010)
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type
Leandro de Padua Silva et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
J. Styczynski et al.
BONE MARROW TRANSPLANTATION (2009)
Haploidentical SCT in children: an update and future perspectives
P. Lang et al.
BONE MARROW TRANSPLANTATION (2008)
Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome
Marie Robin et al.
HAEMATOLOGICA (2007)
Parvovirus B19 infection after transplantation: A review of 98 cases
Albert J. Eid et al.
CLINICAL INFECTIOUS DISEASES (2006)
High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation
MW Schilham et al.
CLINICAL INFECTIOUS DISEASES (2002)
Prevention and treatment of viral infections in stem cell transplant recipients
P Ljungman
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
